Medications designed to release their active ingredients gradually over an extended period, providing sustained therapeutic effects and reducing the frequency of dosing.
A formulation of medication that allows for a prolonged and controlled release of the drug, maintaining therapeutic levels in the bloodstream over an extended period.
Refers to the controlled and gradual release of a medication’s active ingredients over a specific time frame, ensuring a more consistent and sustained impact.
The study of how the body processes medications, including absorption, distribution, metabolism, and excretion, crucial for designing slow-release formulations.
The proportion of a drug that enters the bloodstream and is available for the body to use, a critical factor in determining the effectiveness of slow-release medicines.
The highest concentration of a drug in the bloodstream after administration, often lower and more prolonged with slow-release formulations.
The time between each administration of a medication, with slow-release medicines typically allowing for less frequent dosing compared to immediate-release counterparts.
A formulation technique where the active drug is embedded in a matrix or reservoir, controlling its release over time, commonly used in slow-release medications.
The time it takes for a drug to travel through the digestive system, influencing the absorption and release characteristics of slow-release medicines.
A dosing regimen associated with slow-release medicines, allowing patients to take their medication only once a day due to the sustained release of active ingredients.
The range of drug concentrations in the bloodstream that provides the desired therapeutic effects without causing adverse reactions, often achieved more consistently with slow-release formulations.